Close Menu

NEW YORK (GenomeWeb) – The Wellcome Trust Sanger Institute today announced that spin-off firm 14M Genomics will receive £12.5 million ($19.7 million) in equity financing from investment firm Syncona Partners to develop oncology diagnostic and treatment services.

14M Genomics will combine genomic and clinical data sets for major cancers, which will enable clinicians to stratify patients to better inform diagnosis, prognosis, and treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.